Business Context and Reporting Period
Company: Inmune Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 1, 2025
Event: Announcement of a scientific poster presentation at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders in Vienna, Austria (April 1-5, 2025).
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or comparisons to prior periods are disclosed in this document. The report focuses solely on the upcoming scientific presentation.
Guidance, Outlook, and Risks
Management Commentary: The company intends to present a poster at a major international conference regarding Alzheimer's and Parkinson's diseases.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Verify the content and data presented in the poster at the Vienna conference (refer to Exhibit 99.1).
- Review the attached press release for specific details on the research findings.
- Check subsequent filings for any financial impact or strategic updates resulting from the conference presentation.